Catalyst Wire Dossier Catalyst Wire Dossier

Aquipta

atogepant · AbbVie Deutschland GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Aquipta, covering 2025-06-19 to 2026-08-25. Get the full timeline:

Most recent: EMA Authorised: Aquipta (atogepant) — AbbVie Deutschland GmbH & Co. KG

See pricing